The core team of DRF looks back on more than 20 years of their experience in conducting preclinical studies and commercializing molecules.
We take utmost care in maintaining confidentiality of sponsor's proprietary information. We do not undertake in house R & D in any therapeutic area where we provide commercial services. We have no potential conflict of interest in the sponsor's area of operations.
We have an ambitious approach on quality management as well as quality control.
Innovation Through Customization
DRF has a central innovation team, which works on the development & validation of in vitro, ex vivo & in vivo disease models in multiple therapeutic areas. This allows us to customize solutions for our clients. We encourage you to query us for custom services that you may not find currently listed in our website.
Our team has an understanding of global regulations and systems for compliance with global practices.
Short Turnaround Time
We understand and value the importance of meeting your timelines. From providing rapid response to sponsors in the pre-study phase to the shortest lead time for initiation of your study, our track record shows that we also have among the quickest reporting timelines (98% on time, with >80% early).
We also undertake technical consulting for our clients. These include recommendations for pre IND & IND packages, critical review of comments from regulatory agencies, commercial assessment for products under development & dossier preparation in CTD formats.
Good Partnership Practice
We are more like a partner than a service provider to our clients. We operate on the principle of a joint working relationship by:-
- Establishing measurable goals and objectives
- Education of our team on the expectations of quality and timelines of the project
- Enforcement of the accepted norms and goals
- Regular performance measurement and feedback
- Open communication and conflict resolution process
- Systematic Progress review process